Mode
Text Size
Log in / Sign up

Retrospective study derives age- and sex-specific reference intervals for triglyceride-glucose indexWhy do we need better standards for this common blood measurement?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret cautiously — abstract truncation prevents assessment of the derived age- and sex-specific TyG reference intervals.

This retrospective analysis aimed to establish and validate reference intervals (RIs) for the triglyceride-glucose (TyG) index, a surrogate marker of insulin resistance, using routine health-examination data from adults aged ≥18 years. The derivation cohort excluded individuals with known diabetes, dyslipidemia, or obesity.

The TyG index was calculated as ln[fasting triglyceride (mg/dL) × fasting blood glucose (mg/dL)/2]. After outlier exclusion, authors analyzed the age–TyG relationship using restricted cubic splines and threshold analysis to inform optimal age stratification. Gender- and age-specific RIs were defined as the 2.5th–97.5th percentiles.

Validation used an independent cohort of 127,143 healthy individuals. The abstract text available for review was truncated at the validation success definition, so numeric outcomes, success rates, and final conclusions are not reported here. Derivation cohort size was not reported in the available text.

As a retrospective, observational analysis, associations identified from reference-interval modeling cannot establish causal relationships between TyG index values and clinical outcomes. Safety, tolerability, funding, and conflict-of-interest information were not reported.

Practice relevance is limited until full results are available. Clinicians interested in applying TyG-based RIs should await the complete published report before incorporating these intervals into routine practice.

Imagine getting a routine checkup and wondering if your blood numbers are truly normal. Doctors often rely on reference ranges to make sense of test results, but sometimes we lack those standards. This is the case for a calculation involving triglycerides and glucose, known as the TyG index in medical terms.

Researchers looked at data from routine health exams involving Chinese healthy adults without diabetes or obesity. They aimed to create age- and gender-specific reference intervals for this index. The validation group included 127,143 people, which is a large number to work with.

Here is the catch. The source text ends before reporting the actual results. We do not know if the validation was successful or what the specific intervals look like. This is a retrospective observational study, meaning it shows associations rather than proving cause and effect.

Until we have clear data, doctors lack validated reference intervals for standardized use. This limits how they can apply this tool in clinical practice right now. We must remember that this early stage of research cannot yet guide your personal health decisions today.

What this means for you:
Missing results from this large study mean we cannot use this blood test standard yet.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundThe triglyceride-glucose (TyG) index is a recognized surrogate marker of insulin resistance. However, validated reference intervals (RIs) for the TyG index in large, general healthy populations are currently lacking, limiting its standardized application in clinical practice.MethodsThis retrospective study established and validated TyG index RIs using data from adults (≥18 years) undergoing routine health examinations. The derivation cohort included individuals without known diabetes, dyslipidemia, or obesity. The TyG index was calculated as ln[fasting triglyceride (mg/dL) × fasting blood glucose (mg/dL)/2]. After outlier exclusion, we analyzed the age-TyG relationship using restricted cubic splines and threshold analysis to determine optimal age stratification. Gender- and age-specific RIs were defined as the 2.5th–97.5th percentiles. An independent cohort of 127,143 healthy individuals was used for validation, with success defined as
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.